{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:42:14Z","timestamp":1777898534646,"version":"3.51.4"},"reference-count":43,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Public Health Rep"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>We used data from the 2015 National Association of State Alcohol and Drug Abuse Directors Web-based questionnaire and other sources to demonstrate the range and scope of state initiatives being used to deal with the opioid crisis in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>State alcohol and drug agency directors and designated senior agency managers responded to the questionnaire, which asked respondents about recent opioid-related state-level public health initiatives at their agencies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>State alcohol and drug agencies in all 50 states and the District of Columbia responded, all of which reported that prescription drug misuse was a high priority or the highest priority area for their agencies. Of the 51 respondents, states reported initiatives to educate the general public (n = 48), prescribers (n = 31), patients and families (n = 24), and pharmacists (n = 22) about the risks of opioids. In addition, 29 states had increased funding for medication-assisted treatment of opioid addiction, 28 had expanded the availability of naloxone (an opioid antidote), 26 had established guidelines for safe opioid prescribing, 23 had launched requirements for prescriber use of prescription monitoring programs, 23 had passed Good Samaritan laws to protect those helping treat overdoses, and 14 had enacted legislation to regulate pain clinics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>US state alcohol and drug agencies demonstrated a robust response to the opioid crisis in the United States. They have pursued and expanded on an array of evidence-based initiatives aimed at the opioid crisis. Future public health efforts should focus on maintenance and further expansion of high-quality, evidence-based practices, policies, and programs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0033354916688206","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T18:27:46Z","timestamp":1486060066000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":59,"title":["How States Are Tackling the Opioid Crisis"],"prefix":"10.1177","volume":"132","author":[{"given":"Shalini","family":"Wickramatilake","sequence":"first","affiliation":[{"name":"National Association of State Alcohol and Drug Abuse Directors, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Zur","sequence":"additional","affiliation":[{"name":"Substance Abuse and Mental Health Services Administration, Rockville, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norah","family":"Mulvaney-Day","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, an IBM Company, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda Campopiano von","family":"Klimo","sequence":"additional","affiliation":[{"name":"Substance Abuse and Mental Health Services Administration, Rockville, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Selmi","sequence":"additional","affiliation":[{"name":"National Association of State Alcohol and Drug Abuse Directors, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrick","family":"Harwood","sequence":"additional","affiliation":[{"name":"National Association of State Alcohol and Drug Abuse Directors, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"bibr1-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1508490"},{"key":"bibr2-0033354916688206","unstructured":"Center for Behavioral Health Statistics and Quality. 2014 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs2014\/NSDUH-DetTabs2014.pdf. Accessed May 31, 2016."},{"issue":"26","key":"bibr3-0033354916688206","first-page":"719","volume":"64","author":"Jones CM","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr4-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.01.007"},{"key":"bibr5-0033354916688206","unstructured":"Muhuri PK, Gfroerer JC, Davies MC; Substance Abuse and Mental Health Services Administration. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DR006\/DR006\/nonmedical-pain-reliever-use-2013.htm. Published November 2014. Accessed June 15, 2016."},{"key":"bibr6-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1177\/003335491613100302"},{"key":"bibr7-0033354916688206","unstructured":"Substance Abuse and Mental Health Services Administration. Funding and Characteristics of Single State Agencies for Substance Abuse Services and State Mental Health Agencies, 2013. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. HHS publication (SMA) 15-4926. http:\/\/store.samhsa.gov\/shin\/content\/SMA15-4926\/SMA15-4926.pdf. Accessed May 31, 2016."},{"key":"bibr8-0033354916688206","unstructured":"National Association of State Alcohol and Drug Abuse Directors. State substance abuse agencies and prescription drug misuse and abuse: results from a NASADAD membership inquiry. http:\/\/nasadad.org\/wp-content\/uploads\/2010\/12\/NASADAD-Report-SSAs-and-Prescription-Drug-Misuse-and-Abuse-09.2012.pdf&hl=en_US. Published September 2012. Accessed June 14, 2016."},{"key":"bibr9-0033354916688206","unstructured":"National Association of State Alcohol and Drug Abuse Directors. Overview of state legislation to increase access to treatment for opioid overdose. http:\/\/nasadad.org\/wp-content\/uploads\/2015\/09\/Opioid-Overdose-Policy-Brief-2015-Update-FINAL1.pdf. Published September 2015. Accessed May 20, 2016."},{"key":"bibr10-0033354916688206","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6450a3"},{"key":"bibr11-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.58.6-7.449"},{"key":"bibr12-0033354916688206","unstructured":"National Institute on Drug Abuse. Drugs, brains, and behavior: the science of addiction. https:\/\/teens.drugabuse.gov\/sites\/default\/files\/soa_2014.pdf. NIH publication 14-5605. Published April 2007. Revised 2014. Accessed June 14, 2016."},{"key":"bibr13-0033354916688206","unstructured":"Substance Abuse and Mental Health Services Administration. Finding interventions to prevent or reduce opioid abuse and overdose: selected resources. http:\/\/www.samhsa.gov\/capt\/sites\/default\/files\/resources\/interventions-opioid-overdose.pdf. Published 2014. Accessed May 31, 2016."},{"issue":"26","key":"bibr14-0033354916688206","first-page":"537","volume":"62","author":"Mack KA","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr15-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.68.1.19"},{"key":"bibr16-0033354916688206","unstructured":"Stagman S, Schwarz SW, Powers D; National Center for Children in Poverty. Adolescent substance use in the US. http:\/\/www.nccp.org\/publications\/pub_1008.html. Published May 2011. Accessed May 31, 2016."},{"key":"bibr17-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1007\/s10964-010-9524-7"},{"key":"bibr18-0033354916688206","unstructured":"Substance Abuse and Mental Health Services Administration. Substance Abuse Among Older Adults. Rockville, MD: US Department of Health and Human Services; 1998. HHS publication (SMA) 12-3918. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64419\/pdf\/Bookshelf_NBK64419.pdf. Revised 2012. Accessed June 14, 2016."},{"key":"bibr19-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"bibr20-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01128.x"},{"key":"bibr21-0033354916688206","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1"},{"key":"bibr22-0033354916688206","unstructured":"US Food and Drug Administration. FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose [news release]. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm473505.htm. Published November 18, 2015. Accessed October 14, 2016."},{"issue":"3","key":"bibr23-0033354916688206","first-page":"235","volume":"88","author":"Hawk KF","year":"2015","journal-title":"Yale J Biol Med"},{"key":"bibr24-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1080\/10826080701801261"},{"key":"bibr25-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n03_11"},{"key":"bibr26-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"issue":"06","key":"bibr27-0033354916688206","first-page":"101","volume":"61","author":"Wheeler E","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr28-0033354916688206","unstructured":"Centers for Medicare & Medicaid Services. The role of a prescription drug monitoring program in reducing prescription drug diversion, misuse, and abuse. https:\/\/www.cms.gov\/Medicare-Medicaid-Coordination\/Fraud-Prevention\/Medicaid-Integrity-Education\/Downloads\/drugdiversion-drugmonitoring-factsheet.pdf. Published February 2016. Accessed December 6, 2016."},{"key":"bibr29-0033354916688206","unstructured":"National Alliance for Model State Drug Laws. Status of prescription monitoring programs. http:\/\/www.namsdl.org\/library\/55F8ABFD-A368-2686-A5B7E9AAABBC27A0. Published 2016. Accessed May 31, 2016."},{"key":"bibr30-0033354916688206","unstructured":"National Association of State Controlled Substances Authorities. State profiles. http:\/\/www.nascsa.org\/stateprofiles.htm. Updated 2015. Accessed May 31, 2016."},{"key":"bibr31-0033354916688206","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2012.7.12936"},{"key":"bibr32-0033354916688206","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2015.02.540"},{"key":"bibr33-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2012.01327.x"},{"key":"bibr34-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2009.12.011"},{"key":"bibr35-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01062.x"},{"key":"bibr36-0033354916688206","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.4\/hkleber"},{"key":"bibr37-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1086\/508180"},{"key":"bibr38-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.694598"},{"key":"bibr39-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.3.277"},{"key":"bibr40-0033354916688206","unstructured":"Substance Abuse and Mental Health Services Administration. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005. HHS publication (SMA) 12-4214. http:\/\/store.samhsa.gov\/shin\/content\/\/SMA12-4214\/SMA12-4214.pdf. Updated 2014. Accessed June 16, 2016."},{"issue":"26","key":"bibr41-0033354916688206","first-page":"569","volume":"63","author":"Johnson H","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr42-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2013.10.015"},{"key":"bibr43-0033354916688206","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-013-9814-y"}],"container-title":["Public Health Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0033354916688206","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0033354916688206","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0033354916688206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:33:35Z","timestamp":1777628015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0033354916688206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1177\/0033354916688206"],"URL":"https:\/\/doi.org\/10.1177\/0033354916688206","relation":{},"ISSN":["0033-3549","1468-2877"],"issn-type":[{"value":"0033-3549","type":"print"},{"value":"1468-2877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}